The total return over the past 12 months is +94.75% vs. +16.94% for the S&P 500. So far it's up +82.00% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +93.50% | +12.78% | (13.97%) | +1.85% | +9.58% | +11.20% |
| Total Return CAGR | +94.75% | +13.50% | (13.52%) | +2.29% | +10.21% | +12.21% |
| Revenue CAGR | +3.04% | +4.43% | +12.45% | +11.04% | +14.16% | +16.01% |
| Net Income CAGR | N/A | +38.18% | +3.45% | (7.11%) | (2.04%) | +2.28% |
| EPS CAGR | N/A | +92.86% | +13.08% | (8.91%) | (2.94%) | +1.31% |
| Free Cash Flow CAGR | +57.12% | +13.52% | +4.63% | +20.54% | +12.94% | +17.26% |
| Operating Cash Flow CAGR | +45.48% | +10.97% | +4.54% | +12.16% | +12.77% | +16.84% |
| Dividends CAGR | 0.00% | 0.00% | 0.00% | 0.00% | +2.38% | +1.24% |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Mesa Laboratories, Inc. (MLAB)
| Year | Start price | End price | MLAB Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $78.50 | $142.23 | +82.00% | +14.51% | +67.49% |
| 2025 | $131.87 | $78.50 | (40.05%) | +17.72% | (57.77%) |
| 2024 | $104.77 | $131.87 | +26.59% | +24.89% | +1.70% |
| 2023 | $166.21 | $104.77 | (36.65%) | +26.19% | (62.84%) |
| 2022 | $328.09 | $166.21 | (49.18%) | (18.17%) | (31.01%) |
| 2021 | $286.64 | $328.09 | +14.73% | +28.74% | (14.01%) |
| 2020 | $249.40 | $286.64 | +15.22% | +18.37% | (3.15%) |
| 2019 | $208.39 | $249.40 | +20.01% | +31.22% | (11.21%) |
| 2018 | $124.30 | $208.39 | +68.27% | (4.56%) | +72.83% |
| 2017 | $122.75 | $124.30 | +1.74% | +21.70% | (19.96%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
